190 related articles for article (PubMed ID: 8548050)
1. Medical therapy with somatostatin analogues for acromegaly.
Sassolas G
Eur J Endocrinol; 1995 Dec; 133(6):675-7. PubMed ID: 8548050
[No Abstract] [Full Text] [Related]
2. [Pasireotide as a new second-line treatment option].
Strathaus RS
Med Monatsschr Pharm; 2015 May; 38(5):194-5. PubMed ID: 26364410
[No Abstract] [Full Text] [Related]
3. Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
Jenkins PJ; Akker S; Chew SL; Besser GM; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2000 Dec; 53(6):719-24. PubMed ID: 11155094
[TBL] [Abstract][Full Text] [Related]
4. The use of a GH receptor antagonist in patients with acromegaly resistant to somatostatin analogs.
Colao A; Pivonello R; Cappabianca P; Auriemma RS; De Martino MC; Ciccarelli A; de Divitiis E; Lombardi G
J Endocrinol Invest; 2003; 26(10 Suppl):53-6. PubMed ID: 15497660
[TBL] [Abstract][Full Text] [Related]
5. Growth-hormone and prolactin excess.
Colao A; Lombardi G
Lancet; 1998 Oct; 352(9138):1455-61. PubMed ID: 9808008
[TBL] [Abstract][Full Text] [Related]
6. Effect of high dose somatostatin analogue on growth hormone concentrations in acromegaly.
Sandler LM; Burrin JM; Joplin GF; Bloom SR
Br Med J (Clin Res Ed); 1988 Mar; 296(6624):751-2. PubMed ID: 2894886
[No Abstract] [Full Text] [Related]
7. [Long-term treatment of acromegaly with a somatostatin analog].
Vest S
Ugeskr Laeger; 1987 Aug; 149(34):2263. PubMed ID: 2897734
[No Abstract] [Full Text] [Related]
8. Somatostatin analogs in acromegaly.
Freda PU
J Clin Endocrinol Metab; 2002 Jul; 87(7):3013-8. PubMed ID: 12107192
[No Abstract] [Full Text] [Related]
9. Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly.
Chanson P; Boerlin V; Ajzenberg C; Bachelot Y; Benito P; Bringer J; Caron P; Charbonnel B; Cortet C; Delemer B; Escobar-Jiménez F; Foubert L; Gaztambide S; Jockenhoevel F; Kuhn JM; Leclere J; Lorcy Y; Perlemuter L; Prestele H; Roger P; Rohmer V; Santen R; Sassolas G; Scherbaum WA; Schopohl J; Torres E; Varela C; Villamil F; Webb SM
Clin Endocrinol (Oxf); 2000 Nov; 53(5):577-86. PubMed ID: 11106918
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic value of somatostatin and its analogues.
Farooqi S; Bevan JS; Sheppard MC; Wass JA
Pituitary; 1999 Jun; 2(1):79-88. PubMed ID: 11081176
[TBL] [Abstract][Full Text] [Related]
11. Pegvisomant Treatment in Acromegaly.
Neggers SJ; Muhammad A; van der Lely AJ
Neuroendocrinology; 2016; 103(1):59-65. PubMed ID: 25792221
[TBL] [Abstract][Full Text] [Related]
12. [Advancing acromegaly with low growth hormone levels. Influence of an analog of somatostatin administered in continuous subcutaneous infusion].
Leblanc H; Lebouc Y; Saltiel H; Thote A; Passa P
Presse Med; 1988 Feb; 17(4):164. PubMed ID: 2894669
[No Abstract] [Full Text] [Related]
13. Long term treatment of acromegaly with a long acting analogue of somatostatin.
Ch'ng LJ; Sandler LM; Kraenzlin ME; Burrin JM; Joplin GF; Bloom SR
Br Med J (Clin Res Ed); 1985 Jan; 290(6464):284-5. PubMed ID: 2857104
[No Abstract] [Full Text] [Related]
14. Somatostatin analogs in the treatment of acromegaly: the choice is now possible.
Chanson P
Eur J Endocrinol; 2000 Nov; 143(5):573-5. PubMed ID: 11078979
[No Abstract] [Full Text] [Related]
15. Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome.
Geffner ME; Nagel RA; Dietrich RB; Kaplan SA
J Pediatr; 1987 Nov; 111(5):740-3. PubMed ID: 2889819
[No Abstract] [Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
Ma P; Wang Y; van der Hoek J; Nedelman J; Schran H; Tran LL; Lamberts SW
Clin Pharmacol Ther; 2005 Jul; 78(1):69-80. PubMed ID: 16003295
[TBL] [Abstract][Full Text] [Related]
17. The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly.
Colao A; Auriemma RS; Pivonello R
Pituitary; 2016 Apr; 19(2):210-21. PubMed ID: 26290466
[TBL] [Abstract][Full Text] [Related]
18. Acromegaly: a unique human headache model.
Levy MJ; Bejon P; Barakat M; Goadsby PJ; Meeran K
Headache; 2003; 43(7):794-7. PubMed ID: 12890136
[No Abstract] [Full Text] [Related]
19. Combination treatment with somatostatin analogues and pegvisomant in acromegaly.
Neggers SJ; van der Lely AJ
Growth Horm IGF Res; 2011 Jun; 21(3):129-33. PubMed ID: 21498099
[TBL] [Abstract][Full Text] [Related]
20. Review: long-acting somatostatin analogues.
Long RG
Aliment Pharmacol Ther; 1987 Jun; 1(3):191-200. PubMed ID: 2908749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
